JNCI Monographs · 2011 · 44 citations · 18 references
MedicineOncologyPharmacologyBreast OncologyMolecular OncologyMolecular PharmacologyBreast Cancer ImagingCancer BiomarkersMolecular Tumor ProfilingPharmacodynamics Of Anticancer AgentsTargeted Cancer TherapyTherapy Response AssessmentBiomarker-driven Response PredictionBreast Cancer GenomicsBreast Cancer Response AssessmentPredictive Biomarker AssessmentPredictive Biomarker DiscoveryTherapeutic Response MonitoringTherapeutic Response PredictionTumor Pharmacogenomic Profiling
Antiangiogenic therapy is a promising approach for the treatment of breast cancer. In practice, however, only a subset of patients who receive antiangiogenic drugs demonstrate a significant response. A key challenge, therefore, is to discover biomarkers that are predictive of response to antiangiogenic therapy. To address this issue, we have designed a window-of-opportunity study in which bevacizumab is administered as a short-term first-line treatment to primary breast cancer patients. Central to our approach is the use of a detailed pharmacodynamic assessment, consisting of pre- and post-bevacizumab multi-parametric magnetic resonance imaging scans and core biopsies for exon array gene expression analysis. Here, we illustrate three intrinsic patterns of response to bevacizumab and discuss the molecular mechanisms that may underpin each. Our results illustrate how the combination of dynamic imaging data and gene expression profiles can guide the development of biomarkers for predicting response to antiangiogenic therapy.
18
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text
Medicine, Oncology, Pharmacology +13
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M.L. Ebos, Christina R. Lee, William Cruz‐Muñoz et al. · Cancer Cell · 2009 · 1.7K citations · Full text
Medicine, Oncology, Pharmacology +16
Kathy D. Miller, Linnea Chap, Frankie A. Holmes et al. · Journal of Clinical Oncology · 2005 · 1.3K citations · Full text
Medicine, Oncology, Pharmacology +17
David Miles, Arlene Chan, Luc Dirix et al. · Journal of Clinical Oncology · 2010 · 887 citations
Medicine, Oncology, Pharmacology +17